phase readout
saveNCT07555561: Autologous CD19-CD20-NKG2D-nsBicephali CAR-T for Relapsed/Refractory Central Nervous System Lymphoma
RECRUITINGupdated 2mo ago
community read0 votes
Sponsor: Beijing Boren Hospital. Phase: PHASE1. Conditions: Relapsed/Refractory Central Nervous System Lymphoma, Relapsed/Refractory Primary Central Nervous System Lymphoma, Relapsed/Refractory Secondary Central Nervous System Lymphoma
view source ↗
comments(0)
5-min edit window · permanent after that